Delivery Order SPE2DB22D2005-SPE2DB24FJRG1
Award Date
8/13/24
Potential Completion Date
9/4/24
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Troop Support to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,159.95 firm fixed-price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple Indefinite Delivery Contracts (IDCs) by federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $9,423.24, is for the delivery of PROQUAD VIALS, a pharmaceutical product, with an ultimate completion date of September 18, 2024. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a $240,298.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of PROQUAD VIALS 10S, a pharmaceutical product, with a performance period through May 6, 2024. Amerisourcebergen is a major supplier of prescription drugs, medical devices, and supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of Veterans...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $12,537.75 to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which does not have a set-aside designation, is for the supply of PROQUAD VIALS and has an ultimate completion date of August 15, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies,...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $8,009.95 firm fixed-price order is for the delivery of PROQUAD VIALS, a pharmaceutical product. The order has an ultimate completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several federal Indefinite Delivery Contracts (IDCs) with various agencies, including a $999,999,999 IDC with DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $9,611.94 firm fixed-price delivery order has an ultimate completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly with the Department of Defense (DoD) and Department of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of PROQUAD VIALS. The award has a ceiling value of $2,507.55 and a period of performance ending on September 5, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly to military...